SGA analysis of selected SHIVAD8EO gp120 sequences, present in rebound virus following single mAb immunotherapy, and known to confer resistance to 10-1074 or 3BNC117 mAb. SGA was used to amplify plasma viral RNA following mAb treatment from the plasma of animals KZ6 [day 28], MB6 [day 23], MB8 [day 23], and MCN [day 23]. The gp120 sequences at the top are present in the SHIVAD8EO molecular clone inoculum. Mutations conferring resistance are highlighted in red.